Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase <scp>II</scp> trial (<scp>JMTO LC14</scp>‐01)Susumu Takeuchi, Masaaki Kawahara, Takashi Hirose et al.|Cancer Medicine|2023Cited by 8
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Nobuhiko Seki, Shigeru Tanzawa et al.|JTO Clinical and Research Reports|2023Cited by 5
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Nobuhiko Seki, Hiroshige Yoshioka et al.|Therapeutic Advances in Medical Oncology|2025Cited by 3